1f57: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1f57" size="450" color="white" frame="true" align="right" spinBox="true" caption="1f57, resolution 1.75Å" /> '''CARBOXYPEPTIDASE A C...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1f57.jpg|left|200px]]<br /><applet load="1f57" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1f57.jpg|left|200px]]<br /><applet load="1f57" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1f57, resolution 1.75&Aring;" />
caption="1f57, resolution 1.75&Aring;" />
'''CARBOXYPEPTIDASE A COMPLEX WITH D-CYSTEINE AT 1.75 A'''<br />
'''CARBOXYPEPTIDASE A COMPLEX WITH D-CYSTEINE AT 1.75 A'''<br />


==Overview==
==Overview==
D-Cysteine differs from the antiarthritis drug D-penicillamine by only two, methyl groups on the beta-carbon yet inhibits carboxypeptidase A (CPD) by, a distinct mechanism: D-cysteine binds tightly to the active site zinc, while D-penicillamine catalyzes metal removal. To investigate the, structural basis for this difference, we solved the crystal structure of, carboxypeptidase A complexed with D-cysteine (D-Cys) at 1.75-A resolution., D-Cys binds the active site zinc with a sulfur ligand and forms additional, interactions with surrounding side chains of the enzyme. The structure, explains the difference in potency between D-Cys and L-Cys and provides, insight into the mechanism of D-penicillamine inhibition. D-Cys binding, induces a concerted motion of the side chains around the zinc ion, similar, to that found in other carboxypeptidase-inhibitor crystal structures and, along a limited path. Analysis of concerted motions of CPD and, CPD-inhibitor crystal structures reveals a clustering of these structures, into distinct groups. Using the restricted conformational flexibility of a, drug target in this type of analysis could greatly enhance efficiency in, drug design.
D-Cysteine differs from the antiarthritis drug D-penicillamine by only two methyl groups on the beta-carbon yet inhibits carboxypeptidase A (CPD) by a distinct mechanism: D-cysteine binds tightly to the active site zinc, while D-penicillamine catalyzes metal removal. To investigate the structural basis for this difference, we solved the crystal structure of carboxypeptidase A complexed with D-cysteine (D-Cys) at 1.75-A resolution. D-Cys binds the active site zinc with a sulfur ligand and forms additional interactions with surrounding side chains of the enzyme. The structure explains the difference in potency between D-Cys and L-Cys and provides insight into the mechanism of D-penicillamine inhibition. D-Cys binding induces a concerted motion of the side chains around the zinc ion, similar to that found in other carboxypeptidase-inhibitor crystal structures and along a limited path. Analysis of concerted motions of CPD and CPD-inhibitor crystal structures reveals a clustering of these structures into distinct groups. Using the restricted conformational flexibility of a drug target in this type of analysis could greatly enhance efficiency in drug design.


==About this Structure==
==About this Structure==
1F57 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with ZN and DCY as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Carboxypeptidase_A Carboxypeptidase A], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.17.1 3.4.17.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1F57 OCA].  
1F57 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bos_taurus Bos taurus] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=DCY:'>DCY</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Carboxypeptidase_A Carboxypeptidase A], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.17.1 3.4.17.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1F57 OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Carboxypeptidase A]]
[[Category: Carboxypeptidase A]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Aalten, D.M.van.]]
[[Category: Aalten, D M.van.]]
[[Category: Chong, C.R.]]
[[Category: Chong, C R.]]
[[Category: Joshua-Tor, L.]]
[[Category: Joshua-Tor, L.]]
[[Category: DCY]]
[[Category: DCY]]
Line 21: Line 21:
[[Category: metalloprotease inhibitor]]
[[Category: metalloprotease inhibitor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 14:37:48 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:34:59 2008''